26 research outputs found
The insulin polymorphism -23Hph increases the risk for type 1 diabetes mellitus in the Romanian population
The insulin -23Hph and IGF2 Apa polymorphisms were genotyped in Romanian patients with T1DM (n = 204), T2DM (n = 215) or obesity (n = 200) and normoponderal healthy subjects (n = 750). The genotypes of both polymorphisms were distributed in concordance with Hardy-Weinberg equilibrium in all groups. The -23Hph AA genotype increased the risk for T1DM (OR: 3.22, 95%CI: 2.09-4.98, p < 0,0001), especially in patients without macroalbuminuria (OR: 4.32, 95%CI: 2.54-7.45, p < 0,0001). No other significant association between the alleles or genotypes of insulin -23Hph and IGF2 Apa and diabetes or obesity was identified
New genetic loci link adipose and insulin biology to body fat distribution.
Body fat distribution is a heritable trait and a well-established predictor of adverse metabolic outcomes, independent of overall adiposity. To increase our understanding of the genetic basis of body fat distribution and its molecular links to cardiometabolic traits, here we conduct genome-wide association meta-analyses of traits related to waist and hip circumferences in up to 224,459 individuals. We identify 49 loci (33 new) associated with waist-to-hip ratio adjusted for body mass index (BMI), and an additional 19 loci newly associated with related waist and hip circumference measures (P < 5 × 10(-8)). In total, 20 of the 49 waist-to-hip ratio adjusted for BMI loci show significant sexual dimorphism, 19 of which display a stronger effect in women. The identified loci were enriched for genes expressed in adipose tissue and for putative regulatory elements in adipocytes. Pathway analyses implicated adipogenesis, angiogenesis, transcriptional regulation and insulin resistance as processes affecting fat distribution, providing insight into potential pathophysiological mechanisms
New susceptibility loci associated with kidney disease in type 1 diabetes
WOS:000309817900008Diabetic kidney disease, or diabetic nephropathy (DN), is a major complication of diabetes and the leading cause of end-stage renal disease (ESRD) that requires dialysis treatment or kidney transplantation. In addition to the decrease in the quality of life, DN accounts for a large proportion of the excess mortality associated with type 1 diabetes (T1D). Whereas the degree of glycemia plays a pivotal role in DN, a subset of individuals with poorly controlled T1D do not develop DN. Furthermore, strong familial aggregation supports genetic susceptibility to DN. However, the genes and the molecular mechanisms behind the disease remain poorly understood, and current therapeutic strategies rarely result in reversal of DN. In the GEnetics of Nephropathy: an International Effort (GENIE) consortium, we have undertaken a meta-analysis of genome-wide association studies (GWAS) of T1D DN comprising ∼2.4 million single nucleotide polymorphisms (SNPs) imputed in 6,691 individuals. After additional genotyping of 41 top ranked SNPs representing 24 independent signals in 5,873 individuals, combined meta-analysis revealed association of two SNPs with ESRD: rs7583877 in the AFF3 gene (P = 1.2×10(-8)) and an intergenic SNP on chromosome 15q26 between the genes RGMA and MCTP2, rs12437854 (P = 2.0×10(-9)). Functional data suggest that AFF3 influences renal tubule fibrosis via the transforming growth factor-beta (TGF-β1) pathway. The strongest association with DN as a primary phenotype was seen for an intronic SNP in the ERBB4 gene (rs7588550, P = 2.1×10(-7)), a gene with type 2 diabetes DN differential expression and in the same intron as a variant with cis-eQTL expression of ERBB4. All these detected associations represent new signals in the pathogenesis of DN.Peer reviewe
Rapid Detection of Human Torque Teno Viruses Using High-Resolution Melting Analysis
Torque teno viruses (TTVs) are recently discovered DNA viruses, with heterogeneous genomes, highly prevalent in populations worldwide. The species that infect humans are Torque teno virus (TTV), Torque teno midi virus (TTMDV) and Torque teno mini virus (TTMV). High-resolution melting analysis (HRMA) is a sensitive and effective method for genotyping and mutation scanning. Up to now, HRMA has not been utilized for detection of TTVs
P53 and DCC polymorphisms and the risk for colorectal cancer in Romanian patients—A preliminary study
Abstract. Inactivation of tumor suppressor genes p53 and DCC has been frequently observed in colorectal cancer. The aim of this case-control study was to test possible association between polymorphisms g.32008376A>G (rs714) of DCC gene and g.7175464A>G (rs1625895) of p53 gene and colorectal cancer risk in Romanian patients. We investigate these two polymorphisms by PCR-RFLP in individuals with colorectal cancer (n=120, M:W=74:46) and healthy persons (n=60, M:W=32:28). We observed that GG genotype of both genes confer protection for CRC (ORDCC 0.34, 95%CI 0.18-0.66, ORp53 0.28, 95%CI 0.14-0.55). The presence of DCC AA (OR 2.97, 95%CI 0.97-9.08) and p53 GA (OR 3.86, 95%CI 1.89-7.87) genotypes are associated with an increased risk for CRC. The alleles A of both markers are associated with the risk for disease (OR 2.87, 95%CI 1.49-5.50, respectively 3.54, 95%CI 1.81-6.91). We also observed that coinheritance of DCC GG genotype and p53 GG (OR 0.36) or p53 GA (OR 0.23) confer protection for CRC. These apparent discordant results obtained for the p53 gene may be the result of interaction with other markers or a selection bias. Our findings indicate that the p53 and DCC polymorphisms are associated with a risk of CRC in Romanian patients
Molecular analysis of the estrogen receptor alpha gene in men with coronary artery disease: association with disease status
Background: The vasoprotective effects of estrogens are known to be
mediated by their respective estrogen receptors (ER) alpha (ERalpha) and
beta (ERbeta), which are present on the vascular wall. The
amino-terminal part of the ERalpha appears to be important; genetic
alterations in this region have been associated with arterial
hypertension. This region has not been studied in atherosclerotic
disease. In the present study, we examined the association between
coronary artery disease (CAD) and alterations of the NH2-terminal part
of ERalpha coding region. Methods: Genomic DNA was isolated from 50
healthy men and 40 men with CAD confirmed by coronary angiography. The
coding sequences of exons 1 and 2 were amplified by polymerase chain
reaction (PCR) and analyzed by either denaturing gradient gel
electrophoresis (DGGE) or single stranded conformational polymorphism
(SSCP), or both, sequencing and restriction fragment length polymorphism
(RFLP), as appropriate. In the same subjects, biochemical and vascular
parameters were also determined by using the appropriate methodology.
Results: In exon 1, the codon 10 polymorphism was detected in both
patients and healthy men either in heterozygous or homozygous form. The
codon 87 polymorphism was detected mainly in homozygous form and only
five individuals were heterozygotes. No mutations were found in exon 2.
Statistical analysis of the allele distribution for either codon 10 or
87 between patients and healthy men showed no significant difference. In
patients, the biochemical parameters were not statistically
significantly different between ERalpha codon 10 genotypes or alleles.
However, there was a clear effect of the TCT/TCT genotype and TCT allele
on the vascular parameters whereas the right internal carotid artery
(RICA) intima-media thickness was significantly associated with TCT/TCT
genotype and TCT allele. Conclusions: We conclude that ERalpha genotypes
play no role in the incidence of CAD disease, however, ERalpha codon 10
may be a genetic factor controlling some vessels’ angiographic
complications. (C) 2003 Elsevier Science B.V. All rights reserved